Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.

[1]  X. Bonfill Cosp,et al.  Chemotherapy versus best supportive care for extensive small cell lung cancer. , 2013, The Cochrane database of systematic reviews.

[2]  E. Brambilla,et al.  Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients. , 2012, Lung cancer.

[3]  R. Landreneau,et al.  Surgical resection should be considered for stage I and II small cell carcinoma of the lung. , 2012, The Annals of thoracic surgery.

[4]  M. Reck,et al.  Hyponatremia as prognostic factor in small cell lung cancer--a retrospective single institution analysis. , 2012, Respiratory medicine.

[5]  A. Rossi,et al.  Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Coebergh,et al.  Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Bodner,et al.  The elderly patient with surgically resected non-small cell lung cancer — A distinct situation? , 2012, Experimental Gerontology.

[8]  C. Ferreira,et al.  Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy? , 2012, Supportive Care in Cancer.

[9]  B. Cho,et al.  Elevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer , 2011, Yonsei medical journal.

[10]  C. Rudin,et al.  Small Cell Lung Cancer , 2022 .

[11]  M. Fiegl,et al.  Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer. , 2011, Anticancer research.

[12]  T. Schmid,et al.  The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics. , 2011, American journal of clinical pathology.

[13]  U. Gatzemeier,et al.  Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysis. , 2011, Lung cancer.

[14]  B. Cho,et al.  Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients , 2011, Oncology.

[15]  R. Greil,et al.  Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  U. Gatzemeier,et al.  Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis. , 2010, Respiratory medicine.

[17]  O. Hansen,et al.  The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. , 2010, Lung cancer.

[18]  M. Rotman,et al.  Survival outcomes with the use of surgery in limited‐stage small cell lung cancer , 2010, Cancer.

[19]  K. Kiura,et al.  Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results , 2009, PloS one.

[20]  S. Ou,et al.  Prognostic Factors for Survival in Extensive Stage Small Cell Lung Cancer (ED-SCLC): The Importance of Smoking History, Socioeconomic and Marital Statuses, and Ethnicity , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  H. Ohmatsu,et al.  Performance status and sensitivity to first‐line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second‐line chemotherapy , 2008, Cancer.

[22]  L. Seymour,et al.  The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  F. Shepherd,et al.  Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  Edward L Spitznagel,et al.  Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Lambin,et al.  Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Lambin,et al.  Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer , 2004 .

[27]  M. Sheppard,et al.  Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens , 2002, The American journal of surgical pathology.

[28]  A. Twijnstra,et al.  Neurologic disorders in 203 consecutive patients with small cell lung cancer: Results of a longitudinal study , 1996, Cancer.

[29]  R. Ginsberg,et al.  Staging and prognostic factors in small cell lung cancer: a consensus report , 1989 .

[30]  L. Komarek,et al.  [Motor development of children raised in kindergartens]. , 1974, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete.

[31]  L. Stitt,et al.  Prophylactic cranial irradiation for patients with limited-stage small-cell lung cancer with response to chemoradiation. , 2013, Clinical lung cancer.

[32]  F. Shepherd,et al.  Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline , 2006 .